Roivant President, Immunovant CEO Eric Venker sells USD 6.99 million in common shares - ROIV News | RalliesRoivant President, Immunovant CEO Eric Venker sells USD 6.99 million in common shares
R
ROIV• Insider share sale and option exercise
- Roivant Sciences President and Immunovant CEO Eric Venker sold 200,000 common shares on July 27 at a weighted average of USD 34.95.
- He exercised options for 200,000 shares the same day at USD 3.85.
- Directly held common shares fell to 1,613,063.
- Directly held stock options rose to 4,044,834.
•
